The Platform Group's 61% Rout: A Bond Buyback, a Loan Squeeze, and a Make-or-Break Week Ahead

The €5M bond buyback backfires as shares hit 76% low, legal and credit woes mount, but Q1 revenue surges 51% and AEP acquisition deadline looms.

When a company announces a €5 million bond buyback, the usual market response is a sigh of relief. But for The Platform Group, the gesture backfired. Shares slumped a further 8.4% on Thursday to €1.31, dragging the 30-day decline past 61% and leaving the stock more than 76% below its February 52-week high of €5.60. A relative strength index of 22.3 points to extreme oversold territory, yet selling pressure shows no sign of easing.

The buyback, announced via ad-hoc disclosure on 17 June, covers up to €5 million of the company's own bonds. Purchases will begin on 1 July at the Frankfurt and Berlin exchanges, executed by an independent service provider. Management had hoped the programme would underscore financial stability. Instead, the market focused on the gathering storm around the group.

That storm has multiple fronts. On 12 June, manager magazin reported that banks were demanding their money back, citing alleged tax liabilities and potentially forged documents. The Chemnitz public prosecutor’s office is now reviewing whether to open an investigation. LBBW has reportedly terminated a loan and demanded repayment of roughly €6.75 million, while Sparkasse Essen is said to be seeking around €5.1 million. The company has hit back, filing an urgent injunction through law firm LHR and preparing a main action lawsuit, while publishing a formal rebuttal on its investor relations site.

Amid the legal noise, the operational story remains strikingly different. In the first quarter of 2026, revenue jumped 51% to €243.1 million and adjusted EBITDA rose 37% to €21.8 million. For the full year 2025, the platform provider generated €728 million in revenue and €55 million in adjusted operating profit. The chasm between fundamental performance and market valuation is widening by the session, putting management under intense pressure to explain the disconnect.

A critical variable is the planned acquisition of pharmaceutical wholesaler AEP. Cartel clearance has been obtained, but financing — both equity and debt — must be secured by the end of June. If the deal closes, the group’s gross merchandise volume could expand to around €3.0 billion; failure would keep the baseline at €1.7 billion. The outcome is pivotal for the full-year outlook.

The next eight days will test CEO Dominik Benner's ability to restore trust. On 25 June, he presents at an investor conference in Paris. Six days later, on 1 July — the same day the bond buyback kicks off — the annual general meeting takes place in Düsseldorf. Benner is expected to unveil the "Vision 2030" strategy and a new segment structure focused on pharma and service goods. The half-year report is due 20 August, but by then the AEP decision will likely have set the trajectory.

The immediate risk is a retest of the record low of €1.20, a level that looked improbable two months ago. With the buyback yet to begin and the legal and credit challenges unresolved, the burden of proof now rests entirely on the executive suite.